🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/01/1995 | 28,07 | 30,88 | 28,07 | 30,88 | +4,76% | 10,00% | 374 |
| 04/01/1995 | 29,48 | 29,48 | 29,48 | 29,48 | -1,56% | 0,00% | 53 |
| 03/01/1995 | 30,88 | 30,88 | 29,94 | 29,94 | -3,03% | 3,03% | 1.389 |
| 30/12/1994 | 30,88 | 30,88 | 29,01 | 30,88 | +0,00% | 6,06% | 4.862 |
| 29/12/1994 | 30,88 | 30,88 | 30,88 | 30,88 | +0,00% | 0,00% | 53 |
| 28/12/1994 | 29,01 | 31,82 | 28,07 | 30,88 | +10,00% | 12,90% | 8.068 |
| 27/12/1994 | 28,31 | 29,01 | 27,14 | 28,07 | -6,25% | 6,61% | 374 |
| 23/12/1994 | 26,20 | 29,94 | 26,20 | 29,94 | +10,35% | 14,29% | 668 |
| 22/12/1994 | 29,01 | 29,01 | 27,14 | 27,14 | +0,00% | 6,45% | 1.015 |
| 21/12/1994 | 22,46 | 29,94 | 22,46 | 27,14 | +11,54% | 33,33% | 10.045 |
| 20/12/1994 | 26,20 | 26,20 | 22,46 | 24,33 | +4,00% | 14,29% | 5.263 |
| 19/12/1994 | 26,20 | 29,01 | 23,39 | 23,39 | -11,50% | 21,43% | 6.332 |
| 16/12/1994 | 27,60 | 27,60 | 26,43 | 26,43 | -5,83% | 4,24% | 534 |
| 15/12/1994 | 29,94 | 29,94 | 28,07 | 28,07 | -3,23% | 6,25% | 3.313 |
| 14/12/1994 | 29,01 | 29,01 | 29,01 | 29,01 | +3,33% | 0,00% | 240 |
| 13/12/1994 | 29,01 | 29,94 | 28,07 | 28,07 | -11,76% | 6,45% | 17.927 |
| 12/12/1994 | 31,82 | 31,82 | 29,01 | 31,82 | +9,68% | 8,82% | 935 |
| 09/12/1994 | 29,01 | 31,82 | 29,01 | 29,01 | +0,00% | 9,68% | 3.874 |
| 08/12/1994 | 31,82 | 31,82 | 29,01 | 29,01 | +0,00% | 8,82% | 374 |
| 07/12/1994 | 29,01 | 31,82 | 29,01 | 29,01 | +0,00% | 9,68% | 3.366 |
| 06/12/1994 | 29,94 | 31,82 | 29,01 | 29,01 | +0,00% | 9,37% | 11.996 |
| 05/12/1994 | 32,75 | 32,75 | 29,01 | 29,01 | -8,82% | 11,43% | 2.618 |
| 02/12/1994 | 32,75 | 32,75 | 29,94 | 31,82 | -2,86% | 8,57% | 427 |
| 01/12/1994 | 34,62 | 34,62 | 32,75 | 32,75 | -7,89% | 5,41% | 6.946 |
| 30/11/1994 | 35,56 | 35,56 | 35,56 | 35,56 | +0,00% | 0,00% | 0 |
| 29/11/1994 | 35,09 | 35,56 | 34,62 | 35,56 | -2,56% | 2,67% | 8.950 |
| 28/11/1994 | 37,43 | 37,43 | 35,09 | 36,49 | -2,50% | 6,25% | 1.416 |
| 25/11/1994 | 37,43 | 37,43 | 34,62 | 37,43 | -2,44% | 7,50% | 14.053 |
| 23/11/1994 | 38,37 | 41,17 | 38,37 | 38,37 | -4,65% | 7,32% | 3.420 |
| 22/11/1994 | 40,24 | 42,11 | 40,24 | 40,24 | -4,44% | 4,65% | 5.023 |